Ascentage Pharma Group International (AAPG) Shares Outstanding (Weighted Average) (2022 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Shares Outstanding (Weighted Average) for 4 consecutive years, with $52.6 million as the latest value for Q4 2025.
- For Q4 2025, Shares Outstanding (Weighted Average) rose 25.17% year-over-year to $52.6 million; the TTM value through Dec 2025 reached $52.6 million, up 25.17%, while the annual FY2025 figure was $37000.0, 27.59% up from the prior year.
- Shares Outstanding (Weighted Average) hit $52.6 million in Q4 2025 for Ascentage Pharma Group International, up from $42.1 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $52.6 million in Q4 2025 and bottomed at $281.21 in Q4 2022.
- Average Shares Outstanding (Weighted Average) over 4 years is $33.5 million, with a median of $40.6 million recorded in 2023.
- Year-over-year, Shares Outstanding (Weighted Average) soared 13942528.92% in 2023 and then increased 7.25% in 2024.
- Ascentage Pharma Group International's Shares Outstanding (Weighted Average) stood at $281.21 in 2022, then skyrocketed by 13942528.92% to $39.2 million in 2023, then rose by 7.25% to $42.1 million in 2024, then grew by 25.17% to $52.6 million in 2025.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $52.6 million, $42.1 million, and $39.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.